GNRH1 and early-onset autosomal dominant Alzheimer disease: Considering the feasible harmful role of GnRH-R overactivation in the pathogenesis of Alzheimer’s disease, both animal experiments [145,146] and clinical trials [147,148] with GnRH analogs were carried out to check their effect on the progress of Alzheimer’s disease.